Lirussi et al., 1989 - Google Patents

Cholestasis of total parenteral nutrition: bile acid and bile lipid metabolism in parenterally nourished rats

Lirussi et al., 1989

Document ID: 10159899641670259260
Author: Lirussi F; Vaja S; Murphy G; Dowling R
Publication year: 1989
Publication venue: Gastroenterology

External Links

Cited by

Snippet

As food in the intestine “drives” the enterohepatic circulation and bile acids influence bile flow, we postulated that the cholestasis of total parenteral nutrition might be due to bile acid changes, and the cholelithiasis and biliary sludge of total parenteral nutrition to bile lipid …

Continue reading at www.sciencedirect.com (other versions)

239000003613 bile acid 0 title abstract description 154

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication	Publication Date	Title
Hardison et al.	1981	Nature of bile acid maximum secretory rate in the rat
Vlahcevic et al.	1970	Diminished bile acid pool size in patients with gallstones
Grundy et al.	1969	The interaction of cholesterol absorption and cholesterol synthesis in man
Turley et al.	1979	Regulation of biliary cholesterol output in the rat: dissociation from the rate of hepatic cholesterol synthesis, the size of the hepatic cholesteryl ester pool, and the hepatic uptake of chylomicron cholesterol.
DenBesten et al.	1973	The different effects on the serum lipids and fecal steroids of high carbohydrate diets given orally or intravenously
Cronholm et al.	1967	Bile acids in portal blood of rats fed different diets and cholestyramine: bile acids and steroids 189
Lirussi et al.	1989	Cholestasis of total parenteral nutrition: bile acid and bile lipid metabolism in parenterally nourished rats
Dietschy	1968	Mechanisms for the intestinal absorption of bile acids
Javitt et al.	1968	Effect of sodium taurolithocholate on bile flow and bile acid excretion
Tennent et al.	1960	Plasma cholesterol lowering action of bile acid binding polymers in experimental animals
Dowling et al.	1970	Effects of controlled interruption of the enterohepatic circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis, and pool size in the rhesus monkey
Fischer et al.	1974	Effect of dietary chenodeoxycholic acid and lithocholic acid in the rabbit
Low-Beer et al.	1969	Effects of sulfation of taurolithocholic and glycolithocholic acids on their intestinal transport
Allan et al.	1976	Lithocholate metabolism during chemotherapy for gallstone dissolution. 2. Absorption and sulphation.
Li et al.	1990	Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats
Hardison et al.	1977	Influence of hepatic taurine concentration on bile acid conjugation with taurine.
Andersen et al.	1988	Altered bile acid profiles in duodenal bile and urine in diabetic subjects
Smallwood et al.	1972	Fetal bile salt metabolism: II. Hepatic excretion of endogenous bile salt and of a taurocholate load
Clark et al.	1969	Bile salt regulation of fatty acid absorption and esterification in rat everted jejunal sacs in vitro and into thoracic duct lymph in vivo
Bilhartz et al.	1988	Bile salt hydrophobicity influences cholesterol recruitment from rat liver in vivo when cholesterol synthesis and lipoprotein uptake are constant
Raicht et al.	1974	Effects of sodium taurochenodeoxycholate and sodium taurocholate on cholesterol absorption in the rat
Schmassmann et al.	1993	Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans
Tyor et al.	1971	Metabolism and transport of bile salts in the intestine
Nugent et al.	1959	A comparative study of the metabolism of hydrocortisone and prednisolone
Aldini et al.	1992	Bile acid active and passive ileal transport in the rabbit: effect of luminal stirring